Home / Stocks / Rainbow Childrens Med Ltd
RAINBOW

Rainbow Childrens Med Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹1,240.8

Change

-17.2 (-1.37%)

Open

₹1,259.9

Prev. Close

₹1,258.0

Day High

₹1,264.3

Day Low

₹1,235.0

Volume Analysis

Traded

369,751

Delivered

266,251

Delivery %

72.01%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (31.0%)

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,287.7 ₹1,276.0 ₹1,258.4 ₹1,246.7 ₹1,229.1 ₹1,217.4 ₹1,199.8
Fibonacci ₹1,276.0 ₹1,264.81 ₹1,257.89 ₹1,246.7 ₹1,235.51 ₹1,228.59 ₹1,217.4
Camarilla ₹1,248.86 ₹1,246.17 ₹1,243.49 ₹1,246.7 ₹1,238.11 ₹1,235.43 ₹1,232.74

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-5.67%

1 Week

-4.01%

1 Month

+2.63%

3 Months

-13.42%

6 Months

-8.43%

1 Year

-7.26%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹322.78

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

15.6%

Net margin 15.55% × asset turnover 0.58x × equity multiplier 1.73x

Company Overview

Sector

Healthcare

Market Cap

₹12,607 Cr

P/E (TTM)

43.0

ROE

16.7%

Book Value

₹169.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Rainbow Childrens Med Ltd holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 68/100. The strongest factor is Cash Flow (92/100), while Valuation (8/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (31.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

68/100 — Good

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

85

Growth

78

Valuation

8

Cash Flow

92

Corporate Governance

78

Momentum

39

Institutional Ownership

59

Business Quality

83

Risk & Volatility

64

Liquidity

84

From Screener.in

  • +Company's median sales growth is 22.8% of last 10 years
  • −Stock is trading at 7.35 times its book value

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Rainbow Hospitals to hold in-person NDR analyst meetings in Singapore on November 18-19, 2026.

Transcript of Earnings Conference Call on the Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Newspaper publication of Financial Results for the quarter and half year ended September 30, 2026.

Audio recording of Q2 FY27 earnings call held on November 2, 2026, is now available online.

Q2 FY27 results: revenue up 23%, Nellore and Guntur hospitals started operations, new Group CFO appointed.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 333 336 341 330 417 398 370 353 445 445 460 470 548
Expenses + 215 218 236 236 270 264 255 249 296 298 315 335 378
Operating Profit 118 118 106 94 147 134 115 104 149 147 145 135 170
OPM % 35.0% 35.0% 31.0% 28.0% 35.0% 34.0% 31.0% 29.0% 33.0% 33.0% 31.0% 29.0% 31.0%
Other Income + 8 9 13 12 11 13 15 20 8 11 4 13 8
Interest 13 14 17 18 18 18 18 18 19 20 20 21 22
Depreciation 27 28 32 34 35 35 34 34 36 40 41 42 45
Profit before tax 85 85 69 53 105 94 77 71 102 98 87 84 112
Tax % 26.0% 26.0% 26.0% 26.0% 25.0% 27.0% 27.0% 25.0% 26.0% 24.0% 10.0% 26.0% 25.0%
Net Profit + 63 63 51 40 79 69 57 54 76 74 78 63 84
EPS in Rs 6 6 5 4 8 7 6 5 7 7 8 6 8
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 6 10 8 15 25 18 8 7 7 12 24 33 23

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 169 234 321 402 543 719 650 974 1,174 1,297 1,516 1,703 1,923
Expenses + 128 204 266 332 391 519 485 666 774 865 1,022 1,155 1,327
Operating Profit 41 30 55 69 151 201 165 308 400 432 494 548 596
OPM % 24.0% 13.0% 17.0% 17.0% 28.0% 28.0% 25.0% 32.0% 34.0% 33.0% 33.0% 32.0% 31.0%
Other Income + 10 16 11 10 8 10 10 19 31 37 51 42 35
Interest 3 3 3 4 42 48 46 56 58 63 77 82 84
Depreciation 9 18 22 28 60 69 73 83 90 112 138 151 167
Profit before tax 38 24 41 47 58 93 56 187 282 295 330 358 380
Tax % 35.0% 28.0% 24.0% 22.0% 22.0% 41.0% 29.0% 26.0% 25.0% 26.0% 26.0% 21.0% —
Net Profit + 25 17 31 36 45 55 40 139 212 218 244 282 299
EPS in Rs 3 2 3 4 5 6 4 14 21 21 24 27 29
Dividend Payout % 7.0% 11.0% 7.0% 12.0% 10.0% 16.0% 0.0% 14.0% 14.0% 14.0% 13.0% 13.0% —
Sales growth 38 38 38 25 35 33 -10 50 21 11 17 12 23

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 166 275 308 307 317 350 391 498 958 1,157 1,367 1,547 1,612
Borrowings + 22 24 26 24 476 501 529 592 570 765 764 891 968
Other Liabilities + 34 41 55 73 89 123 116 112 140 146 145 236 276
Total Liabilities 231 349 399 448 926 1,019 1,081 1,296 1,771 2,170 2,377 2,775 2,959
Fixed Assets + 78 123 174 296 702 702 772 858 931 1,253 1,398 1,756 1,886
CWIP 35 31 7 12 23 43 29 6 23 20 28 79 103
Investments 7 2 6 0 3 10 18 22 58 308 571 404 354
Other Assets + 111 194 212 140 199 265 262 409 759 590 380 535 616
Total Assets 231 349 399 448 926 1,019 1,081 1,296 1,771 2,170 2,377 2,775 2,959
Equity Capital 9 9 9 44 44 44 44 94 102 102 102 102 102

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 26 17 36 48 127 170 143 224 329 321 396 420
Cash from Investing Activity + -20 -107 -33 -42 -117 -117 -83 -175 -465 -226 -268 -259
Cash from Financing Activity + -7 93 -1 -7 -9 -52 -61 -44 143 -102 -118 -147
Net Cash Flow -1 3 1 -2 2 2 -1 4 7 -7 10 14
Free Cash Flow -35 -46 -21 -103 42 96 67 162 188 -32 250 204
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 95 88 79 88 94 95 102 93 103 95 97 95

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 49.83% → 49.83%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Others 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.04% 0.12% 0.18% 0.4%
Public 12.23% 11.37% 11.53% 11.2% 11.16% 11.14% 11.11% 10.82% 11.4% 11.68% 11.39% 11.84%
Promoters 49.83% 49.83% 49.87% 49.85% 49.85% 49.85% 49.85% 49.85% 49.84% 49.84% 49.84% 49.83%
FII 22.32% 24.04% 24.78% 25.12% 25.12% 23.69% 23.6% 21.85% 19.24% 17.24% 16.03% 14.66%
DII 15.62% 14.76% 13.81% 13.84% 13.87% 15.31% 15.44% 17.46% 19.49% 21.12% 22.56% 23.28%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Rainbow Childrens Med Ltd (this stock) 12,607 43.0 7.34 16.7%
Concord Biotech Limited 12,146 42.6 5.86 12.9%
Marksans Pharma Limited 13,347 23.8 4.0 15.2%
Metropolis Healthcare Ltd 11,711 50.7 7.13 13.6%
Sudeep Pharma Limited 13,545 71.9 14.14 25.2%
Viyash Scientific Limited 11,285 46.6 3.56 7.39%
Akums Drugs And Pharma L 11,279 29.9 3.22 8.45%

Which Mutual Funds Hold Rainbow Childrens Med Ltd?

Frequently Asked Questions about Rainbow Childrens Med Ltd

Community Sentiment

What are other investors saying about Rainbow Childrens Med Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.